Why MS mainly affects women. Organizational models for the treatment of the disease
Multiple Sclerosis and health policy: optimizing care with efficient management
Personalized multiple sclerosis therapy and information technology
it
Prof. Giancarlo Comi
New approaches to this pathology
it
Prof. Giancarlo Comi
Epigenetics and cognitive reserve affect the quality of life in MS
it
Prof. Giancarlo Comi
The importance of early diagnosis for the prognosis of MS
it
Prof. Giancarlo Comi
Optimizing resources and reducing waste
it
Francesco S. Mennini
The Italian MS Association: profile and goals
it
Prof. Mario A. Battaglia
Right to treatment: the patient’s point of view
it
Prof. Mario A. Battaglia
Why MS mainly affects women. Organizational models for the treatment of the disease
it
Prof. Giancarlo Comi
Who is responsible for informing the public about the risk factors of MS
it
Prof. Giancarlo Comi
Teva's commitment to Multiple Sclerosis - Hubert P. D'Alissac
it
Multiple sclerosis: a disease with high social and economic impact
it
Francesco S. Mennini
Research development in multiple sclerosis treatment - Hubert P. D'Alissac, TEVA
it
Teva: the development of research on the treatment of multiple sclerosis
en
Personalized treatment for MS: information technology and nets of specialized centres
en
Prof. Giancarlo Comi